Evidence map›Paper›PMID 25027966›Full record

ArticleCellular & molecular immunology2015

The activating effect of IFN-γ on monocytes/macrophages is regulated by the LIF-trophoblast-IL-10 axis via Stat1 inhibition and Stat3 activation.

Angham Dallagi, Julie Girouard, Jovane Hamelin-Morrissette, Rachel Dadzie, Laetitia Laurent, Cathy Vaillancourt, Julie Lafond, Christian Carrier, Carlos Reyes-Moreno

Open access · bronzeAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Drug design, development and therapy · 2025
    Article
  12. Frontiers in cellular and infection microbiology · 2025
    Article
  13. Article
  14. Article
  15. Unveiling the immune dynamics ofInfection and immunity · 2024
    Article
  16. Article
  17. Tumor ABCC4-mediated release of PGE2 induces CD8International journal of biological sciences · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Angham Dallagi1] Groupe de Recherche en Oncologie et Endocrinologie Moléculaires, Université du Québec à Trois-Rivières, département de biologie médicale, Trois-Rivières, PQ, G9A 5H7, Canada [2] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada.
Julie Girouard1] Groupe de Recherche en Oncologie et Endocrinologie Moléculaires, Université du Québec à Trois-Rivières, département de biologie médicale, Trois-Rivières, PQ, G9A 5H7, Canada [2] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada.
Jovane Hamelin-Morrissette1] Groupe de Recherche en Oncologie et Endocrinologie Moléculaires, Université du Québec à Trois-Rivières, département de biologie médicale, Trois-Rivières, PQ, G9A 5H7, Canada [2] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada.
Rachel Dadzie1] Groupe de Recherche en Oncologie et Endocrinologie Moléculaires, Université du Québec à Trois-Rivières, département de biologie médicale, Trois-Rivières, PQ, G9A 5H7, Canada [2] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada.
Laetitia Laurent1] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada [2] INRS-Institut Armand-Frappier, Université du Québec, Laval, PQ, H7V 1B7, Canada.
Cathy Vaillancourt1] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada [2] INRS-Institut Armand-Frappier, Université du Québec, Laval, PQ, H7V 1B7, Canada.
Julie Lafond1] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada [2] Université du Québec à Montréal, département des sciences biologiques, Montréal, QC, H3C 3P8, Canada.
Christian CarrierCentre Hospitalier Régional de Trois-Rivières, Trois-Rivières, PQ, G9A 1Y1, Canada.
Carlos Reyes-Moreno1] Groupe de Recherche en Oncologie et Endocrinologie Moléculaires, Université du Québec à Trois-Rivières, département de biologie médicale, Trois-Rivières, PQ, G9A 5H7, Canada [2] Centre de recherche BioMed UQAM-UQTR-INRS, Montréal, PQ, H3C 3P8, Canada.
Institut National de la Recherche Scientifique · CAUniversité du Québec à Trois-Rivières · CACentre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon gamma (IFN-γ) and leukemia inhibitory factor (LIF) are key gestational factors that may differentially affect leukocyte function during gestation. Because IFN-γ induces a pro-inflammatory phenotype in macrophages and because trophoblast cells are principal targets of LIF in the placenta, we investigated whether and how soluble factors from trophoblast cells regulate the effects of IFN-γ on macrophage activation. IFN-γ reduces macrophage motility, but enhances Stat1 activation, pro-inflammatory gene expression and cytotoxic functions. Soluble factors from villous cytotrophoblasts (vCT+LIF cells) and BeWo cells (BW/ST+LIF cells) that were differentiated in the presence of LIF inhibit macrophage Stat1 activation but inversely sustain Stat3 activation in response to IFN-γ. vCT+LIF cells produce soluble factors that induce Stat3 activation; this effect is partially abrogated in the presence of neutralizing anti-interleukin 10 (IL-10) antibodies. Moreover, soluble factors from BW/ST+LIF cells reduce cell proliferation but enhance the migratory responses of monocytes. In addition, these factors reverse the inhibitory effect of IFN-γ on monocyte/macrophage motility. BW/ST+LIF cells also generate IFN-γ-activated macrophages with enhanced IL-10 expression, but reduced tumor-necrosis factor alpha (TNF-α), CD14 and CD40 expression as well as impaired cytotoxic function. Additional assays performed in the presence of neutralizing anti-IL-10 antibodies and exogenous IL-10 demonstrate that reduced macrophage cytotoxicity and proliferation, but increased cell motility result from the ability of trophoblast IL-10 to sustain Stat3 activation and suppress IFN-γ-induced Stat1 activation. These in vitro studies are the first to describe the regulatory role of the LIF-trophoblast-IL-10 axis in the process of macrophage activation in response to pro-inflammatory cytokines.

Indexed as

Cell Line, TumorChorionic VilliFemaleGene Expression RegulationHumansInterferon-gammaInterleukin-10Leukemia Inhibitory FactorMacrophage ActivationMacrophagesMonocytesPregnancySTAT1 Transcription FactorSTAT3 Transcription FactorTrophoblastsInterferon-gammaInterleukin-10Leukemia Inhibitory FactorLIF protein, humanSTAT1 Transcription FactorSTAT3 Transcription Factor

Identifiers

PMID25027966
PMCPMC4654315
OpenAlexW2126275728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.